Stock data
Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH) reported revenue of US$982.02M and net income of -US$416.28M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$982.02M | — | -US$437.25M | -US$416.28M | — |
| 2024 | US$739.02M | — | -US$443.59M | -US$436.37M | — |
| 2023 | US$563.95M | — | -US$564.73M | -US$479.45M | — |
| 2022 | US$449.54M | — | -US$544.38M | -US$654.59M | — |
| 2021 | US$373.65M | — | -US$411.00M | -US$384.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$334.98M | -US$120.14M | — |
| 2026-03-31 | US$301.67M | -US$112.08M | — |
| 2025-12-31 | US$281.27M | -US$128.49M | — |
| 2025-09-30 | US$265.20M | -US$92.72M | — |
| 2025-06-30 | US$232.09M | -US$99.90M | — |
| 2025-03-31 | US$203.47M | -US$95.16M | — |
| 2024-12-31 | US$201.81M | -US$111.01M | — |
| 2024-09-30 | US$191.48M | -US$107.75M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.